If NWBO is in Roling Review with the MHRA and the MHRA has in that process questions, would that not be a good reason why it takes this long? The moment the last page is then submitted without any questions left for the MHRA is when the MAA is officially submitted. Of course, after that, it would take only very little time for approval as Senti suggests.
This is what I think what is going on
and who from the senior citizen's management members will then for the coming decade in their 75+ prime lead NWBO into the future? Boynton 78y or Jasinowski 84? And as chairperson Powers 67?
Also, big pharma hardly almost never enters in the construction you described
thats because every step they take in the process is new to them and thus impossible to estimate any timeline. If we had experienced biotech management then this is something that would not happen. You should know that by now. Im angered by it as well but I already (a half years ago) decided to accept it.
its mind-boggling that on one hand LS asserts that LP has created enormous Shareholder Value bc of MIA Approval for Advent then pretends to not understand why this shareholders value is not being reflected in NWBO's market cap and then, on the other hand, conveniently refuses to mention that Advent Bio Ltd is NOT an NWBO subsidiary which it should have been. As if Larry Smith does not understand to gain market value from a certain asset one should actually own it, as if the market is dumb.
Perhaps LS meant that NWBO should gain value now that it no longer has to pay for the founding of Advent ?
well Im not sure if MAA was ready 100% at the time MIA was granted. They probably had to include some details/info about the MIA certificate that they didn't know prior to the date MIA was provided. But yes it would be absurd beyond nuts if the MAA has not been submitted yet by now.
If you mean with the company NWBO
My take is that its very difficult for a few MDs to comprehend that DCVAXL amended the SAP to RWE OS. AS AF did, they keep rehashing the trial failed because it did not meet its original PFS endpoint. I do believe the small doubt that has been sawn after JA has partially contributed to larger investment parties waiting before investing. That's why I strongly believe we see a huge increase in market cap after MHRA approval. Not because the UK is a such dominant market but because it will prove the well-respected MHRA fully accepts the amended SAP which I think will give the green light for larger investors to start buying NWBO shares.